This report is the result of a multidisciplinary consultation of experts regarding the future surveillance of invasive meningococcal and Haemophilus influenzae diseases, held at ECDC from 17 to 18 March 2009.
This guidance report lays down the scientific basis for the potential introduction of human papillomavirus (HPV) vaccines in order to help EU Member States to make policy choices
Today, ECDC publishes an update to its 2008 Guidance on human papillomavirus (HPV) vaccines in Europe. The update follows the introduction of vaccination programmes in 19 European countries and new evidence from research studies over the past four years.